Clinical Trials Directory

Trials / Unknown

UnknownNCT03333408

Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Our Lady of the Lake Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Salivary duct stent placement is a common practice to maintain duct patency after salivary duct repair or interventional sialoendoscopy; procedures performed to manage salivary duct pathology such as stenosis, traumatic injury or most commonly salivary duct stones. It is common practice for patients to receive perioperative antibiotics while undergoing interventional sialoendoscopy and postoperative oral antibiotic therapy with Clindamycin or Augmentin for 10-14 days, if a short term (2 week) salivary duct stenting was considered necessary due to the nature of the intervention. However, In reviewing the literature, there are controversial trials that indicate post-operative antibiotics may not be best practice in all surgical scenarios, as the adverse events ie. gastrointestinal disturbances, nausea, Clostridium difficile (C.diff) infection and antibiotic resistance over time surrounding overuse of antibiotics may outweigh the clinical need for the antibiotic regiment and the chances of post-operative infection.

Conditions

Interventions

TypeNameDescription
DRUGPostoperative Oral Antibiotics (Clindamycin or Augmentin)Patients will receive postoperative oral antibiotics (Clindamycin or Augmentin) for 10-14 days upon discharge.

Timeline

Start date
2018-06-15
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2017-11-06
Last updated
2023-11-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03333408. Inclusion in this directory is not an endorsement.